Boris P Nikolaev
Overview
Explore the profile of Boris P Nikolaev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yudintceva N, Nashchekina Y, Mikhailova N, Vinogradova T, Yablonsky P, Gorelova A, et al.
J Biomed Mater Res B Appl Biomater
. 2019 Aug;
108(3):1010-1021.
PMID: 31369698
Reconstructive surgery for urethral defects employing tissue-engineered scaffolds represents an alternative treatment for urethroplasty. The aim of this study was to compare the therapeutic efficacy of the bilayer poly-D,L-lactide/poly-ε-caprolactone (PL-PC)...
2.
Shevtsov M, Nikolaev B, Ryzhov V, Yakovleva L, Dobrodumov A, Marchenko Y, et al.
Nanomedicine
. 2015 Dec;
12(3):611-621.
PMID: 26656626
From The Clinical Editor: Superparamagnetic iron oxides nanoparticles (SPIONs) have been studied extensively as a contrast agent for MRI. Their tissue specificity can be further enhanced by conjugation with various...
3.
Shevtsov M, Nikolaev B, Ryzhov V, Yakovleva L, Marchenko Y, Parr M, et al.
Nanoscale
. 2015 Nov;
7(48):20652-64.
PMID: 26599206
The stress-inducible 72 kDa heat shock protein Hsp70 is known to be expressed on the membrane of highly aggressive tumor cells including high-grade gliomas, but not on the corresponding normal...
4.
Shevtsov M, Nikolaev B, Yakovleva L, Parr M, Marchenko Y, Eliseev I, et al.
J Control Release
. 2015 Nov;
220(Pt A):329-340.
PMID: 26522072
Nanovaccines based on superparamagnetic iron oxide nanoparticles (SPIONs) provide a novel approach to induce the humoral and cell-based immune system to fight cancer. Herein, we increased the immunostimulatory capacity of...
5.
Shevtsov M, Nikolaev B, Yakovleva L, Dobrodumov A, Zhakhov A, Mikhrina A, et al.
Neoplasia
. 2015 Jan;
17(1):32-42.
PMID: 25622897
Cerebral edema commonly accompanies brain tumors and contributes to neurologic symptoms. The role of the interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles (SPION-IL-1Ra) was assessed to analyze its...
6.
Shevtsov M, Nikolaev B, Yakovleva L, Dobrodumov A, Dayneko A, Shmonin A, et al.
Drug Des Devel Ther
. 2014 Jun;
8:639-50.
PMID: 24920887
Recombinant 70 kDa heat shock protein (Hsp70) is an antiapoptotic protein that has a cell protective activity in stress stimuli and thus could be a useful therapeutic agent in the...
7.
Shevtsov M, Pozdnyakov A, Mikhrina A, Yakovleva L, Nikolaev B, Dobrodumov A, et al.
Int J Cancer
. 2014 Apr;
135(9):2118-28.
PMID: 24691976
Chaperone Hsp70 can activate adaptive immunity suggesting its possible application as an antitumor vaccine. To assess the therapeutic capacity of Hsp70 we administered purified chaperone into a C6 glioblastoma brain...
8.
Shevtsov M, Nikolaev B, Yakovleva L, Marchenko Y, Dobrodumov A, Mikhrina A, et al.
Int J Nanomedicine
. 2014 Jan;
9:273-87.
PMID: 24421639
Superparamagnetic iron oxide nanoparticles (SPIONs) conjugated with recombinant human epidermal growth factor (SPION-EGF) were studied as a potential agent for magnetic resonance imaging contrast enhancement of malignant brain tumors. Synthesized...
9.
Shevtsov M, Yakovleva L, Nikolaev B, Marchenko Y, Dobrodumov A, Onokhin K, et al.
Neuro Oncol
. 2013 Dec;
16(1):38-49.
PMID: 24305705
Background: Superparamagnetic iron oxide nanoparticles (SPIONs), due to their unique magnetic properties, have the ability to function both as magnetic resonance (MR) contrast agents, and can be used for thermotherapy....
10.
Ischenko A, Nikolaev B, Kotova T, Vorobeychikov E, Konusova V, Yakovleva L
J Aerosol Med
. 2007 Dec;
20(4):445-59.
PMID: 18158717
The feasibility of efficient aerosol delivery of the human IL-1 receptor antagonist (IL-1Ra) for reduction of acute lung inflammation was demonstrated in a mouse model study. The therapeutic efficacy of...